Post-translational modifications regulating the activity and function of the nuclear factor kappa B pathway
By N. Perkins. Oncogene, 2006
703 citations recorded by the source corpus.
Subfields: Cancer Research, Immunology, Molecular Biology
View Paper: https://www.semanticscholar.org/paper/6f972a5be3330bae0b8e8525f69810567f817307
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Cancer Research
In Immunology
In Molecular Biology
Citations in the corpus
- NF-κB and the immune response (2006, background): “Progress continues to be made in understanding AgR signaling to NF-kB, and this work has led to the appreciation of regulatory ubiquitination events in IKK activation (see reviews by Perkins, 2006; Scheidereit, 2006).”
- Low early-life social class leaves a biological residue manifested by decreased glucocorticoid and increased proinflammatory signaling (2009, background): “And the activity of NF- B itself can be markedly altered by posttranslational modifications, such as acetylation, ubiquitination, and phosphorylation (25).”
- Introduction to NF-κB: players, pathways, perspectives (2006, background): “…the dynamics and direct mechanisms of gene regulation by NF-kB (Hoffmann et al., 2006); post-translational modifications that regulate components of the NF-kB pathway (Perkins, 2006); and the controversial role of reactive oxygen species in the regulation of NF-kB activity (Bubici et al., 2006).”
- Molecular Mechanisms of Treg-Mediated T Cell Suppression (2012, background): “The NF-κB complex itself can be phosphorylated and acetylated , which regulates its transcriptional activity and association with other transcription factors (Li and Verma, 2002; Perkins, 2006).”
- Lysine acetylation: codified crosstalk with other posttranslational modifications (2008, background): “It remains to be established whether similar interplay occurs in p53, FoxO1, RelA (NF-kB subunit) (Perkins, 2006), and CCAAT/enhancer binding protein b (C/EBPb) (Hasselgren, 2007).”